Pharmaceutical

Alvotech and Dr Reddy’s partner to commercialise AVT03

Alvotech has entered into a collaboration with Dr. Reddy's Laboratories for the commercialisation of AVT03 in the US, Europe and the UK.

May 23, 2024 - 04:00
Alvotech and Dr Reddy’s partner to commercialise AVT03
Alvotech has entered into a collaboration with Dr. Reddy's Laboratories for the commercialisation of AVT03 in the US, Europe and the UK.
Read the original article

Tags:

Previous Article

Genmab acquires biotechnology company ProfoundBio in $1.8bn deal

Next Article

AltruBio secures $225m for immune checkpoint programme development

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

FDA approves BeiGene’s TEVIMBRA for oesophageal cancer

FDA approves BeiGene’s TEVIMBRA for oesophageal cancer

Mar 16, 2024

STAT+: Former surgeon general Jerome Adams tries to outrun the shadow of the president he served

STAT+: Former surgeon general Jerome Adams tries to out...

Mar 26, 2023

STAT+: Shareholders elect director’s romantic partner to Biogen’s board

STAT+: Shareholders elect director’s romantic partner t...

Jun 26, 2023